Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin plus dydrogesterone for prevention of preeclampsia
IRCT20241225064169N4Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin and dydrogesterone in preeclampsia, sponsored by Shiraz University of Medical Sciences. Started Dec 2025; status: completed.
02
Drugs
aspirindydrogesterone
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20241225064169N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241225064169N4.